• Award Winning For Medical Education
  • 5* Excellent TrustPilot Rating
  • Pay In 3 Installment Option
  • 10+ Years Teaching Experience

AKT2-170

A new oral anticoagulant drug is being trialled in patients with Deep Vein Thrombosis to see if there are less cases of intracerebral haemorrhage over 1 year compared with Rivaroxaban. 100 patients had the new drug and 5 of these patients had an intracerebral haemorrhage. A further 100 patients who were on Rivaroxaban over this timeframe had 1 patient from their cohort develop an intracerebral haemorrhage.

What is the risk ratio for the new drug?

Pay in 3 interest-free payments

Late fees may apply. Learn more

5% off as a thank you!

Use Coupon 'website5'

🙏 Our simple appreciation for you visiting today...

Dr Aman and Dr Pooja Arora :)

X